← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleAsan Medical CenterPhase 2

nivolumab (Opdivo, Regorafenib/Nivolumab)

Carcinoma, Hepatocellular; Hepatoma · Carcinoma, Hepatocellular

#CarcinomaHepatocellular#Antibody#Phase2#항체#면역항체+5
효능 ORR 42%임상시험 1상태 ACTIVE
AntibodystaleWashington University School of…Phase 1

Relatilmab (Relatilmab)

Advanced Melanoma; Metastatic Melanoma · Advanced Melanoma

#AdvancedMelanoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Relatlimab FDC + Nivolumab)

Metastatic Triple-negative Breast Cancer · Metastatic Triple-negative Breast Cancer

#MetastaticTriple-negativeBreastC#Antibody#Phase2#항체#면역항체+2
효능 ORR 61.9%임상시험 1상태 RECRUITING
AntibodystaleLoyola UniversityPhase 2

infliximab (Remicaide, Remicaide (infliximab))

Toxic Epidermal Necrolysis · Toxic Epidermal Necrolysis

#ToxicEpidermalNecrolysis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleTevaPreclinical

Reslizumab (Reslizumab)

Asthma · Asthma

#Asthma#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of Alabama at Birmin…Phase 1

Retifanlimab, INCAGN02385, INCAGN02390 (Retifanlimab, INCAGN02385, INCAGN02390)

Diffuse Large B Cell Lymphoma; Lymphoma, B-Cell · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#Antibody#Phase1#항체#면역항체+4
효능 ORR 100%임상시험 1상태 DISCONTINUED
AntibodystaleSWOG Cancer Research NetworkPreclinical

Rilotumumab (Rilotumumab)

Recurrent Squamous Cell Lung Carcinoma; Stage IV Squamous Cell Lung Carcinoma AJCC v7 · Recurrent Squamous Cell Lung Carcinoma

#RecurrentSquamousCellLungCarcino#Antibody#Preclinical#항체#면역항체+3
효능 ORR 21%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Arm A (Rituximab, Rituximab (Arm A))

Autoimmune Prematur Ovarian Insuffience · Autoimmune Prematur Ovarian Insuffience

#AutoimmunePrematurOvarianInsuffi#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

Arm B (Rituximab, Rituximab (Arm B))

Autoimmune Prematur Ovarian Insuffience · Autoimmune Prematur Ovarian Insuffience

#AutoimmunePrematurOvarianInsuffi#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

rituximab (Rituxan, MABTHERA® or RITUXAN®, Rituximab (MABTHERA® or RITUXAN®).)

Pemphigus; Auto-immune Thrombocytopenic Purpura · Pemphigus

#Pemphigus#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab (Mabthera, Rituximab, Rituximab (Mabthera) , FFP (Fresh Frozen Plasma))

Advanced Refractory Chronic Lymphocytic Leukemia · FRα

#FR#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab (RTX, Rituximab, Rituximab (RTX) and Azathioprine (AZA))

Granulomatous and Lymphocytic Interstitial Lung Disease · Granulomatous and Lymphocytic Interstiti

#GranulomatousandLymphocyticInter#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

active comparator (Rituximab, Rituximab (active comparator))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

once a week (Rituximab, Rituximab (once a week))

Rituximab; Children · Rituximab

#Rituximab#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

where available (Rituximab, Rituximab (where available))

Non-hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Rituximab + MG4101 (Rituximab + MG4101)

CD20-positive Non-Hodgkin Lymphoma · CD20

#CD20#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

Rituximab + zanubrutinib + lenalidomide (Rituximab + zanubrutinib + lenalidomide)

Overall Survival · Overall Survival

#OverallSurvival#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Rituximab - Bendamustine (Rituximab - Bendamustine)

Follicular Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab - CHOP (Rituximab - CHOP)

Diffuse Large B-cell Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Rituximab - CVP (Rituximab - CVP)

Follicular Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE

68 / 92 페이지

← 이전다음 →